Garton v. United States

CourtCourt of Appeals for the Fifth Circuit
DecidedDecember 3, 1999
Docket99-50196
StatusUnpublished

This text of Garton v. United States (Garton v. United States) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fifth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Garton v. United States, (5th Cir. 1999).

Opinion

UNITED STATES COURT OF APPEALS FOR THE FIFTH CIRCUIT __________________________________________

No. 99-50196 Summary Calender _________________________________________

CHARLES GARTON, ET AL,

Plaintiffs,

WILMA GARTON, Individually, and as the Representative of the Estate of CHARLES GARTON, Deceased,

Plaintiff-Appellant,

v.

UNITED STATES OF AMERICA,

Defendant-Appellee.

__________________________________________

Appeal from the United States District Court for the Western District of Texas (SA-96-CV-53) __________________________________________

December 2, 1999

Before REYNALDO G. GARZA, HIGGINBOTHAM and JONES, Circuit Judges.

PER CURIAM 1:

This appeal arises out of a suit filed under the Federal Tort Claims Act (FTCA), 28 U.S.C.

§§ 1346(b) and 2671-80, alleging that Charles Garton developed hepatocellular carcinoma as a

result of being transfused with hepatitis B and C tainted blood during a 1984 coronary artery

bypass graft surgery performed at a Government hospital. The district court granted judgment in

favor of the Government and, finding no error, we affirm.

I. BACKGROUND

In 1974, Charles Garton was serving a prison term for bank robbery in the Missouri State

1 Pursuant to 5TH CIR. R. 47.5, the court has determined that this opinion should not be published and is not precedent except under the limited circumstances set forth in 5TH CIR. R. 47.5.4. Penitentiary. According to Penitentiary medical records, Mr. Garton had probably contracted

some form of hepatitis by 1963. In March of 1974, Mr. Garton underwent a coronary artery by-

pass graft procedure at the University of Missouri Medical Center. During this surgery,

transfusions of blood and blood products were given.

On March 19, 1984, Charles Garton underwent redo coronary artery bypass graft surgery

at the Audie Murphy Veterans Administration Hospital in San Antonio Texas (Audie Murphy).

Before this surgery occurred, Mr. Garton informed the anesthesiologist of his having previously

contracted hepatitis B. During this surgery, Mr. Garton received transfusions of blood and blood

products from the Wilford Hall Blood Donor Center at Lackland Air Force Base in San Antonio,

Texas.

On December 15, 1993, Charles Garton contacted the Veterans Administration Hospital in

Albuquerque, New Mexico regarding his general complaints of decreased energy and malaise. A

work-up conducted after laboratory tests revealed liver abnormalities. Laboratory studies

conducted in early 1994 revealed hepatocellular carcinoma secondary to chronic hepatitis. At that

time, the treating physicians at the Veterans Administration determined that the blood transfusions

were the source of Garton’s hepatitis. On March 22, 1994, another surgery was performed which

removed 90% of a hepatocellular carcinoma from Garton’s liver.

On May 10, 1994, Mr. Garton filed an “Application for Benefits” under the provisions of

38 U.S.C. § 1151, claiming a disability secondary to an injury that occurred as a result of VA

authorized healthcare. After an investigation, the Department of Veterans Affairs found, on

March 7, 1995, that Mr. Garton was entitled to compensation for his hepatocellular carcinoma.

The Veterans Administration ratings specialist who reviewed the written opinions of the treating

physicians later testified that there was no conclusive evidence establishing that the 1984

transfusion was the cause of Mr. Garton contracting hepatitis B and C. However, the ratings

specialist testified that Mr. Garton was granted benefits because “reasonable doubts” were

resolved in his favor.

2 On May 13, 1994, Mr. Garton was re-admitted to the Veteran’s Hospital in Albuquerque

and underwent daily radiation treatments to address his “post-incomplete tumor resection.” In

August of 1995, Garton presented an FTCA, 28 U.S.C. §§ 1346(b) and 2671-80, Administrative

Claim with the Veteran’s Administration, alleging that Charles Garton developed hepatocellular

carcinoma as a result of being transfused with hepatitis B and C tainted blood during the 1984

coronary artery bypass graft surgery. Specifically, it contended that the Government’s agents

failed to properly screen the blood for hepatitis B and thereby departed from appropriate

standards of care. The Air Force conducted an investigation into whether its agents and

employees had followed appropriate blood banking procedures. This investigation revealed that

most of the blood bank logs regarding Mr. Garton’s 1984 transfusion had been destroyed,

pursuant to Air Force regulations, after 10 years. The Veterans Administration formally denied

Garton’s claim on November 13, 1995 and this lawsuit followed.

At a subsequent bench trial, the Gartons attempted to introduce the undisclosed expert

testimony of one Dr. Cohen concerning proper blood banking procedures. In response to this

surprise testimony, the district court attempted to balance the interest of both parties. The court

allowed the Gartons’ expert to testify on the subject of blood banking but also allowed the

Government to call a rebuttal witness, Dr. Kalmin, on the same subject. The district court

allowed in the testimony of two other expert witnesses over the Gartons’ objection that they were

not qualified. The district court made several findings of fact and law, including that no adverse

inference should be drawn from the Government’s failure to preserve evidence of blood screening

logs. The district court found that the standard of care in 1984 was to screen blood for hepatitis

B, but that there was no test available at that time to screen blood for hepatitis C. Thus, there

was no duty to screen blood for hepatitis C in 1984 and any claim based on such duty was

dismissed. The district court concluded that “the most credible evidence established that in all

reasonable medical probability, Garton’s hepatocellular carcinoma was not the result of exposure

to hepatitis B in the 1984 blood transfusion.” Accordingly, the district court ordered that

3 judgment be entered in favor of the Government. This appeal followed. Mr. Garton died on

October 30, 1998 as a result of the hepatocellular carcinoma before this appeal could be

addressed. Mr. Garton’s wife was allowed to continue the suit.

II. DISCUSSION

1. Undisclosed Expert Witness

The Gartons contend that the district court abused its discretion in denying their motion

for a new trial because the district court allowed the Government to present the expert testimony

of a previously non-disclosed witness, Dr. Kalmin. Finding no error, we affirm.

The Gartons failed to disclose that their expert witness, Dr. Stephen Cohen, would proffer

opinions regarding blood banking procedures. The record shows that, during discovery, the

Gartons failed to respond to Government interrogatories asking which experts, if any, the Gartons

would call regarding blood banking procedures. Such non-disclosure was a violation of Rule 26

of the Federal Rules of Civil Procedure.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Garton v. United States, Counsel Stack Legal Research, https://law.counselstack.com/opinion/garton-v-united-states-ca5-1999.